OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes M...

por Bilic, Sanela, Dagon, Yossi, Gustafson, Thomas, Johnson, Leslie, Lawler, John, Rudolph-Own, Lori, Gaich, Gregory, Tucker, Edwin
Publicado 2022